Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Pharma Integration S R L has 3 pending office actions in the Chemistry & Materials technology area. These matters are handled by 3 distinct examiners across 3 distinct art units. This means that each of the 3 pending office actions is being reviewed independently by a different examiner. This distribution requires a tailored prosecution strategy for each of the 3 pending office actions.
CHEN, CHANGRU is the busiest examiner with 1 pending office action. With 3 distinct examiners and 3 distinct art units, the company's current chemical portfolio is distributed across different technical divisions. This one-to-one-to-one ratio between 3 actions, 3 examiners, and 3 art units suggests that the pending matters cover distinct chemical processes or materials. The lack of overlap between the 3 pending office actions means that the company must adapt to three different sets of examiner expectations. Each of the 3 pending office actions represents a unique technical challenge in the chemistry sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, CHANGRU | 1 | 48.6% | +40.7% |
| MALLON, BRETT PETERSON | 1 | 65.3% | +26.0% |
| MUTREJA, JYOTI NAGPAUL | 1 | 81.1% | +4.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18543884 | ROBOTIC CONTROL FOR PARTICLE SAMPLING AND MONITORING | MUTREJA, JYOTI NAGPAUL | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18947225 | ARRANGEMENT FOR THE CONTAMINATION-FREE INTRODUCTION OF A STERILE OBJECT FROM A CONTAINER INTO A CONTAINMENT AND METHOD THEREFOR | CHEN, CHANGRU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18947225 | ARRANGEMENT FOR THE CONTAMINATION-FREE INTRODUCTION OF A STERILE OBJECT FROM A CONTAINER INTO A CONTAINMENT AND METHOD THEREFOR | CHEN, CHANGRU | — |
| 18699614 | A FABRICATED AUTOMATED UNMANNED AND GLOVELESS CLEANROOM PROCESSING ENCLOSURE | MALLON, BRETT PETERSON | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| 3762 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18947225 | ARRANGEMENT FOR THE CONTAMINATION-FREE INTRODUCTION OF A STERILE OBJECT FROM A CONTAINER INTO A CONTAINMENT AND METHOD THEREFOR | CHEN, CHANGRU | 1796 | §102§103 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18699614 | A FABRICATED AUTOMATED UNMANNED AND GLOVELESS CLEANROOM PROCESSING ENCLOSURE | MALLON, BRETT PETERSON | 3762 | §103 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18543884 | ROBOTIC CONTROL FOR PARTICLE SAMPLING AND MONITORING | MUTREJA, JYOTI NAGPAUL | 1798 | §103 | Non-Final OA | — | Pending | Dec 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPharma Integration S R L has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Changru Chen has the most, with 1 of Pharma Integration S R L's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
